Transcripta Bio
Transcripta Bio valuation and funding history | Last updated: August 13, 2024
Current Valuation
N/A
As of August 13, 2024
Total Funding Raised
$32.6M
Last Round
Early Stage VC
$10.0M
Last Funding
Aug 2024
Funding date
Capital Efficiency
N/A
Valuation / Funding
Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones
No funding history available
Funding data has not been imported for this company yet
Valuation Analysis
Current Valuation Metrics
Transcripta Bio is currently valued at N/A as of August 13, 2024. The company has raised a total of $32.6M in funding.
What is Transcripta Bio Worth in 2026?
Transcripta Bio is a leading private company in the technology sector. Track Transcripta Bio's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.
How Transcripta Bio Valuation is Determined
Private company valuations like Transcripta Bio's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.